JP2022547695A5 - - Google Patents

Info

Publication number
JP2022547695A5
JP2022547695A5 JP2022516041A JP2022516041A JP2022547695A5 JP 2022547695 A5 JP2022547695 A5 JP 2022547695A5 JP 2022516041 A JP2022516041 A JP 2022516041A JP 2022516041 A JP2022516041 A JP 2022516041A JP 2022547695 A5 JP2022547695 A5 JP 2022547695A5
Authority
JP
Japan
Prior art keywords
sequence
flavivirus
protein
domain
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022516041A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022547695A (ja
JP7663250B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/075541 external-priority patent/WO2021048402A1/en
Publication of JP2022547695A publication Critical patent/JP2022547695A/ja
Publication of JP2022547695A5 publication Critical patent/JP2022547695A5/ja
Application granted granted Critical
Publication of JP7663250B2 publication Critical patent/JP7663250B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022516041A 2019-09-13 2020-09-11 ラッサウイルスワクチン Active JP7663250B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19197202.5 2019-09-13
EP19197202 2019-09-13
PCT/EP2020/075541 WO2021048402A1 (en) 2019-09-13 2020-09-11 Lassavirus vaccines

Publications (3)

Publication Number Publication Date
JP2022547695A JP2022547695A (ja) 2022-11-15
JP2022547695A5 true JP2022547695A5 (https=) 2023-09-14
JP7663250B2 JP7663250B2 (ja) 2025-04-16

Family

ID=68137784

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022516041A Active JP7663250B2 (ja) 2019-09-13 2020-09-11 ラッサウイルスワクチン

Country Status (8)

Country Link
US (1) US12558410B2 (https=)
EP (1) EP4041300A1 (https=)
JP (1) JP7663250B2 (https=)
CN (1) CN114728054A (https=)
AU (1) AU2020346382A1 (https=)
BR (1) BR112022004378A2 (https=)
WO (1) WO2021048402A1 (https=)
ZA (1) ZA202203730B (https=)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005042014A1 (en) 2003-10-29 2005-05-12 The University Of Queensland West nile virus vaccine
JP5779352B2 (ja) * 2008-03-14 2015-09-16 サノフィ パスツール バイオロジクス リミテッド ライアビリティ カンパニー 複製欠損フラビウイルスワクチンおよびワクチンベクター
GB201307528D0 (en) 2013-04-26 2013-06-12 Univ Leuven Kath Bacterial artificial chromosomes
BR102016018430A2 (pt) * 2016-08-10 2018-02-27 Fundação Oswaldo Cruz Cassete de expressão heteróloga, constructo de dna e composição vacinal para imunizar contra flavivírus e/ou outros patógenos.
WO2019018501A1 (en) 2017-07-18 2019-01-24 Geovax Inc. COMPOSITIONS AND METHODS FOR GENERATING LASV IMMUNE RESPONSE

Similar Documents

Publication Publication Date Title
US12410215B2 (en) Mutated glycoprotein of vesicular stomatitis virus
Shi et al. Golgi localization of Hantaan virus glycoproteins requires coexpression of G1 and G2
Kinney et al. Nucleotide sequence of the 26 S mRNA of the virulent Trinidad donkey strain of Venezuelan equine encephalitis virus and deduced sequence of the encoded structural proteins
JP2023524054A5 (https=)
Pfeifer et al. Structure of the influenza C glycoprotein gene as determined from cloned DNA
JP2024541466A5 (https=)
CN116096736A (zh) 新型冠状病毒rbd融合蛋白
JP2005525128A5 (https=)
Seabaugh et al. Development of a chimeric sindbis virus with Enhancedper OsInfection ofAedes aegypti
JP2022547695A5 (https=)
EP1558276B1 (en) Flaviviris fusion inhibitors
Morsy et al. Activation of an influenza virus A/turkey/Oregon/71 HA insertion variant by the subtilisin-like endoprotease furin
Papa et al. Genetic characterization of the M RNA segment of a Balkan Crimean‐Congo hemorrhagic fever virus strain
TAKAHASHI et al. Nucleotide sequence of the capsid protein gene of bean yellow mosaic virus chlorotic spot strain
JP2023510544A5 (https=)
JP2002538775A5 (https=)
Lee et al. Analysis of the role of the amino-terminal peptide of vaccinia virus structural protein precursors during proteolytic processing
Pekarik Secreted trimeric viral envelope proteins as a tool for new vaccine design and biochemical assays
HK40117175A (en) Mutated glycoprotein of vesicular stomatitis virus
HK40117176A (en) Mutated glycoprotein of vesicular stomatitis virus
ZA202203730B (en) Lassavirus vaccines
WO2026057803A1 (en) Nanoparticle-based delivery systems
US20080234184A1 (en) Vectors For the Co-Expression of Membrane Domains of Viral Envelope Proteins and Uses Thereof
Fields et al. INFLUENZA VIRUS A/PR/8/34 GENES: SEQUENCING BY A SHOTGUN APPROACH
JPH0430791A (ja) 構造蛋白質遺伝子、組換えベクター、組換えウイルス、ポリペプチドおよびポリペプチドの製造方法